registrieren | anmelden | FAQ      [?] 

Tag pharma [40 articles]

Recent papers classified by the tag pharma.
  • Penetratin and derivatives acting as antifungal agents
    European Journal of Medicinal Chemistry (29 February 2008)
    by M Masman, A Rodriguez, M Raimondi, S Zacchino, P Luiten, C Somlai, T Kortvelyesi, B Penke, R Enriz
    posted to pharma by zfekete on 2008-10-15 09:16:27 as **
  • The 3D Structure of the Binding Pocket of the Human Oxytocin Receptor for Benzoxazine Antagonists, Determined by Molecular Docking, Scoring Functions and 3D-QSAR Methods
    Journal of Computer-Aided Molecular Design, Vol. 19, No. 5. (May 2005), pp. 341-356.
    by Balazs Jojart, Tamas Martinek, Arpad Marki
    posted to vhts pharma by zfekete on 2008-10-15 09:22:53 as **
  • Learning from failed trials in ALS
    The Lancet Neurology (05 November 2007)
    by M Swash
    posted to phase-3 pharma minocycline als by zfekete on 2008-12-04 13:09:26 as **
  • A social science framework for the analysis of health technology regulation: the risks and benefits of innovative pharmaceuticals in a comparative context
    Health, Risk & Society, Vol. 4, No. 3. (2002), pp. 305-324.
    by John Abraham
    posted to sociology risk-benefit policy pharma medicine by ultrascichick on 2008-11-18 02:26:37 as ** along with 1 person ricmilne
  • Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry
    Sociology, Vol. 40, No. 2. (1 April 2006), pp. 297-314.
    by Joan Busfield
    posted to history-medicine pharma sociology science-studies by ultrascichick on 2008-11-18 01:22:30 as ** along with 1 person ricmilne
  • Biopharmaceuticals: Biochemistry and Biotechnology
    (19 September 2003)
    by Gary Walsh
    posted to textbook pharma biology by ultrascichick on 2008-11-18 21:30:23 as **
  • Analgesia (Handbook of Experimental Pharmacology)
    (10 November 2006)
    posted to pharma textbook medicine by ultrascichick on 2008-11-17 16:43:25 as **
  • Book Review: Meaning, Medicine and the `Placebo Effect.' By Daniel Moerman; Social Lives of Medicines. By Susan Reynolds Whyte, Sjaak van der Geest, and Anita Hardon
    Culture, Medicine and Psychiatry, Vol. 28, No. 2., 245.
    by Peter J Guarnaccia
    posted to anthropology culture get medanth medical pharma by rayoulike on 2008-06-28 18:57:14 as ****
  • Manufacturing Consensus
    Culture, Medicine and Psychiatry, Vol. V30, No. 2. (30 June 2006), pp. 135-156.
    by David Healy
    posted to citation get medanth medical pharma politics writing by rayoulike on 2008-06-28 18:42:06 as ** along with 3 people and 2 groups paultr pseudopharm jago Global_health_enterprise_architecture Knowledge_Economy_Reform
  • Pharmaceutical Virtue
    Culture, Medicine and Psychiatry, Vol. 30, No. 2. (June 2006), pp. 157-174.
    by Martin, Emily
    posted to get history medanth medical pharma politics by rayoulike on 2008-06-28 18:49:38 as **
  • Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential.
    Br J Pharmacol (14 January 2008)
    by S M M Lawrie, J Hall, A M M McIntosh, D G G Cunningham-Owens, E C C Johnstone
    posted to pharma neuroimaging mol genetic and by prerona on 2008-09-04 15:55:42 as ** along with 1 person isami
  • Prodrugs: design and clinical applications
    Nat Rev Drug Discov, Vol. 7, No. 3. (February 2008), pp. 255-270.
    by Jarkko Rautio, Hanna Kumpulainen, Tycho Heimbach, Reza Oliyai, Dooman Oh, Tomi Jarvinen, Jouko Savolainen
    posted to pharma prodrugs by middledomain on 2008-02-29 10:31:46 as **
  • Global Pharmaceuticals : Ethics, Markets, Practices
    (15 May 2006)
    by Adriana Petryna
    posted to healthcare pharma ethnography access by magdaw on 2008-11-16 03:58:47 as *** along with 2 people and 1 group eraikhel qbert medanthro
  • Evaluation of a complex intervention for changing professional behaviour: the Evidence Based Out Reach (EBOR) Trial
    Journal of Health Services Research and Policy, Vol. 7, No. 4., pp. 230-238.
    by I Nazareth, N Freemantle, C Duggan, J Mason, A Haines
    posted to cme cpg education failure forresearch marketing outreach pharma quality by linga on 2005-05-15 08:18:58 as *****
  • Clinical forecasting in drug development
    Nature Reviews Drug Discovery, Vol. 6, No. 2., pp. 107-108.
    by Asher D Schachter, Marco F Ramoni
    posted to graphical_models industry pharma by hmk on 2007-06-09 19:15:23 as **
  • Managing the drug discovery/development interface
    Drug Discovery Today, Vol. 2, No. 10. (October 1997), pp. 436-444.
    by T Kennedy
    posted to chem diplomarbeit pharma rbc_bme08 by girschick on 2007-06-12 14:16:15 as ***
  • The price of innovation: new estimates of drug development costs
    Journal of Health Economics, Vol. 22, No. 2. (March 2003), pp. 151-185.
    by Joseph A Dimasi, Ronald W Hansen, Henry G Grabowski
    posted to chem diplomarbeit pharma rbc_bme08 by girschick on 2007-06-12 13:55:44 as ***
  • A maximum common substructure-based algorithm for searching and predicting drug-like compounds
    Bioinformatics, Vol. 24, No. 13. (1 July 2008), pp. i366-374.
    by Yiqun Cao, Tao Jiang, Thomas Girke
    posted to chem pharma prediction by girschick on 2008-06-27 14:18:00 as ** along with 1 person reyez
  • Predicting undesirable drug interactions with promiscuous proteins in silico.
    Drug Discov Today, Vol. 9, No. 6. (15 March 2004), pp. 276-285.
    by S Ekins
    posted to chem drug-drug pharma by girschick on 2008-06-25 10:22:41 as ** along with 2 people kuhn tomb
  • Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
    Bioinformatics, Vol. 24, No. 13. (1 July 2008), pp. i232-240.
    by Yoshihiro Yamanishi, Michihiro Araki, Alex Gutteridge, Wataru Honda, Minoru Kanehisa
    posted to chem drug-target pharma by girschick on 2008-06-27 14:15:44 as ** along with 1 person renatomilani
  • Progress in predicting human ADME parameters in silico
    Journal of Pharmacological and Toxicological Methods, Vol. 44, No. 1. ( 2000), pp. 251-272.
    by Sean Ekins, Chris L Waller, Peter W Swaan, Gabriele Cruciani, Steven A Wrighton, James H Wikel
    posted to adme chem cyp pharma by girschick on 2008-06-25 10:21:05 as **
  • Pharmaceutical Reason : Knowledge and Value in Global Psychiatry (Cambridge Studies in Society and the Life Sciences)
    (05 January 2006)
    by Andrew Lakoff
    posted to anthropology drugs medical pharma by eraikhel on 2006-05-23 23:24:24 as ** along with 1 person and 1 group qbert medanthro
  • Drugs, Industry, and Academia
    Science, Vol. 320, No. 5883. (20 June 2008), 1563.
    by Garret A Fitzgerald
    posted to drug-discovery pharma by dullhunk on 2008-06-23 12:13:52 as ** along with 1 person and 2 groups jago Global_health_enterprise_architecture Global_patent_pools
  • Female Sexual Dysfunction: A Case Study of Disease Mongering and Activist Resistance
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Leonore Tiefer
    posted to pharma by dbogartoit on 2006-06-13 16:17:54 as ** along with 1 person Borelli
  • Pharmaceutical Marketing and the Invention of the Medical Consumer
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Kalman Applbaum
    posted to pharma by dbogartoit on 2006-06-13 16:18:33 as ** along with 3 people Borelli ricmilne Jordy
  • Pharmaceutical R&D in the spotlight: why is there still unmet medical need?
    Drug Discov Today, Vol. 12, No. 23-24. (December 2007), pp. 998-1006.
    by EF Schmid, DA Smith
    posted to drug_discovery pharma by cmmorel on 2007-12-29 10:37:42 as **
  • Funding pharmaceutical innovation through direct tax credits
    Health Economics, Policy and Law, Vol. 2, No. 03. (2007), pp. 267-284.
    by Kristina M Lybecker, Robert A Freeman
    posted to credits funding innovation pharma tax by cmmorel on 2008-07-23 13:39:22 as **
  • Developing Drugs For Developing Countries
    Health Aff, Vol. 25, No. 2. (1 March 2006), pp. 313-324.
    by David B Ridley, Henry G Grabowski, Jeffrey L Moe
    posted to developing_countries drugs neglected_diseases pharma voucher by cmmorel on 2006-03-07 15:27:01 as ** along with 1 person acpereira
  • Influence of pharmaceutical funding on the conclusions of meta-analyses
    BMJ (16 November 2007), bmj.39381.655845.BE.
    by Richard A Epstein
    posted to bias epidemiology pharma by claudine on 2007-11-20 05:19:34 as ** along with 1 person cmvalma
  • notes Prioritising neglected diseases related to poverty
    BMJ, Vol. 331, No. 7507. (2 July 2005), 12.
    by Rhona Macdonald
    posted to health pharma poverty by claudine on 2005-07-05 03:05:20 as **
  • Cholinesterase Inhibitors: Drugs Looking for a Disease?
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Marina Maggini, Nicola Vanacore, Roberto Raschetti
    posted to pharma skepticism by Borelli on 2006-07-21 18:03:56 as read
  • Bigger and Better: How Pfizer Redefined Erectile Dysfunction
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Joel Lexchin
    posted to pharma skepticism by Borelli on 2006-07-21 18:01:04 as read
  • The Fight against Disease Mongering: Generating Knowledge for Action
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Ray Moynihan, David Henry
    posted to pharma skepticism by Borelli on 2006-07-21 17:58:20 as read
  • Disease Mongering in Drug Promotion: Do Governments Have a Regulatory Role?
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Barbara Mintzes
    posted to pharma skepticism by Borelli on 2006-07-21 18:04:20 as read
  • Giving Legs to Restless Legs: A Case Study of How the Media Helps Make People Sick
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Steven Woloshin, Lisa M Schwartz
    posted to pharma skepticism by Borelli on 2006-07-21 18:03:32 as read
  • The Latest Mania: Selling Bipolar Disorder
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by David Healy
    posted to pharma skepticism by Borelli on 2006-07-21 18:02:17 as read
  • Medicine Goes to School: Teachers as Sickness Brokers for ADHD
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Christine B Phillips
    posted to pharma skepticism by Borelli on 2006-07-21 18:01:36 as read along with 1 person Davidps
  • Combating Disease Mongering: Daunting but Nonetheless Essential
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Iona Heath
    posted to pharma skepticism by Borelli on 2006-07-21 18:03:13 as read
  • Selling sickness: the pharmaceutical industry and disease mongering.
    BMJ, Vol. 324, No. 7342. (13 April 2002), pp. 886-891.
    by R Moynihan, I Heath, D Henry
    posted to medicine pharma science skepticism by Borelli on 2006-03-31 15:55:34 as read
  • Awareness and Attitudes about Disease Mongering among Medical and Pharmaceutical Students
    PLoS Medicine, Vol. 3, No. 4. (1 April 2006)
    by Jairaj C Kumar, Abhizith Deoker, Ashwini Kumar, Arunachalam Kumar, BM Hegde
    posted to pharma skepticism by Borelli on 2006-07-21 18:04:48 as read
    • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/tag/pharma

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.